Healthcare Industry News: DePuy
News Release - June 12, 2007
Bob Purcell Named Exactech Vice President U.S. SalesGAINESVILLE, Fla., June 12 (HSMN NewsFeed) -- Exactech (Nasdaq: EXAC ), a developer and producer of bone and joint restoration products including orthopaedic implants and biologic materials, announced today the appointment of Bob Purcell as vice president of U.S. sales. Purcell comes to Exactech from Smith & Nephew where he was the vice president of corporate accounts.
Purcell has more than 20 years of successful sales and management experience in orthopaedics. His 10 years as vice president of sales for DePuy Orthopaedics spanned a period when the company grew from $100 million in revenue to more than $750 million in revenue. During his 15-year career at DePuy, he also served as a regional sales manager, a senior product manager with worldwide responsibility for hip products, and as a Mid-Atlantic Territory general manager where he managed 35 sales representatives.
Subsequent to his tenure at DePuy, Purcell worked in the corporate headquarters of HCA in Nashville and in 2001 joined Smith & Nephew as vice president of corporate accounts. Early in his orthopaedic career, he was a sales representative for both Ethicon and Zimmer. He holds a bachelor's degree from the College of William and Mary.
"During his career, Bob Purcell has been known among his colleagues as a strong relationship-builder with proven leadership ability," said Executive Vice President of Sales and Marketing, David Petty. "He brings to Exactech a unique blend of experience in sales management, sales leadership, marketing and contracting at local and national levels. He will add an important dimension to our understanding of the needs and challenges of our sales organization and will provide effective leadership and support as we continue to build upon the strong momentum we have developed."
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech's orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States and Australia, in addition to more than 25 countries in Europe, Asia and Latin America. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech's press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.
An investment profile on Exactech may be found at http://www.hawkassociates.com/exacprofile.aspx.
Investors may contact Chief Financial Officer Jody Phillips at (352) 377-1140 or Julie Marshall or Frank Hawkins, Hawk Associates Inc., at (305) 451-1888, e-mail: firstname.lastname@example.org. To receive free notification of future releases for this company, sign up at http://www.hawkassociates.com/email.aspx.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company's expectations or beliefs concerning future events of the company's financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company's dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company's products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.